School of Biomedical Engineering, Huazhong University of Science and Technology (HUST), Wuhan, 430074, China.
School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Curr Pharm Des. 2021;27(9):1170-1184. doi: 10.2174/1874467213666201204154239.
The spread of COVID-19 has become a growing cause of mortalities over the globe since its major outbreak in December 2019. The scientific and medical communities are rallying to study different strains and probable mutations to develop more rapid and reliable molecular diagnostic tests and possible therapeutic approaches for SARS-CoV-2.
In the first section, following the introductory part, we shed light on structural and pathogenic features of SARS-CoV-2 and risk factors related to age, gender, neonatal and comorbidities. The next section summarizes the current diagnostic tests for COVID-19, such as nucleic acid and computed tomography (CT) techniques, with further emphasis on emerging diagnostic approaches for COVID-19.
Further, we also review the ongoing therapeutic practices which can block virus-host interaction, cease viral proliferation or inhibit hyperbolic host immune response with subsections on drug therapy, cell therapy, immunotherapy and herbal medicines that are being used for the possible treatment of patients.
Among the different promising drugs, remdesivir, by inhibiting the RNA-dependent RNA-Polymerase activity, gives much better results, including declined viral load and quick lung tissue recovery. The long-lasting repercussions of COVID-19 have also been discussed at the end. In this review, we have also critically discussed the progress in several vaccines that are under development.
自 2019 年 12 月 COVID-19 大爆发以来,其在全球范围内的传播已成为死亡率不断上升的主要原因。科学界和医学界正在齐心协力研究不同的菌株和可能的突变,以开发更快速、更可靠的 SARS-CoV-2 分子诊断测试和可能的治疗方法。
在引言部分之后的第一节中,我们介绍了 SARS-CoV-2 的结构和发病特征,以及与年龄、性别、新生儿和合并症相关的危险因素。下一节总结了目前用于 COVID-19 的诊断测试,如核酸和计算机断层扫描(CT)技术,并进一步强调了 COVID-19 的新兴诊断方法。
此外,我们还回顾了正在进行的治疗方法,这些方法可以阻断病毒-宿主相互作用、停止病毒增殖或抑制宿主过度的免疫反应,包括药物治疗、细胞治疗、免疫治疗和用于治疗患者的草药。
在不同有前途的药物中,通过抑制 RNA 依赖性 RNA 聚合酶活性的瑞德西韦,结果要好得多,包括降低病毒载量和快速肺组织恢复。COVID-19 的长期影响也在最后进行了讨论。在这篇综述中,我们还对正在开发的几种疫苗的进展进行了批判性讨论。